StockDriftsStockDriftsAdbiotech (179530) has 3 disclosed insider purchases and 1 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩67M ($47K) in reported transaction value. The earliest filing StockDrifts holds for Adbiotech is dated 2024-03-08; the most recent is 2026-06-05. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -9.19%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | BUY | 제3자배정유상증자 | 비케이파트너스투자조합1호 BK Partners Investment Association No. 1 | - | 6.0M | - | - | - |
| 2026-01-19 | BUY | 장외매수 | 정홍걸 Jeong Hong-geol | torture | 174.6K | ₩2,125 | -23.9% | ₩371M ($258K) |
| 2026-01-14 | BUY | 제3자배정유상증자 | 비케이파트너스투자조합2호 BK Partners Investment Association No. 2 | - | 3.3M | ₩1,866 | -13.3% | ₩6.2B ($4.3M) |
| 2025-12-10 | BUY | Market Buy | 김동현 Donghyun Kim | CEO | 1.0K | ₩2,785 | -41.9% | ₩3M ($2K) |
| 2025-11-20 | BUY | 제3자배정유상증자 | 비케이파트너스투자조합1호 BK Partners Investment Association No. 1 | - | 3.4M | ₩3,485 | -53.6% | ₩11.9B ($8.2M) |
| 2025-10-17 | SELL | Market Sell | 최경민 Kyeongmin Choi | moving | -12.0K | ₩3,670 | +55.9% | ₩44M ($31K) |
| 2025-09-24 | SELL | 장외매도 | 정홍걸 Jeong Hong-geol | torture | -1.5M | ₩4,170 | +61.2% | ₩6.1B ($4.2M) |
| 2025-06-05 | SELL | 장외매도 | 정은정 Jeong Eun-jeong | general manager | -620.0K | ₩1,915 | +15.5% | ₩1.2B ($825K) |
| 2025-03-11 | BUY | 유상신주취득 | 박수현 Park Soo-hyun | general manager | 10.0K | ₩1,716 | -5.7% | ₩17M ($12K) |
| 2025-03-11 | BUY | 유상신주취득 | 정은정 Jeong Eun-jeong | general manager | 20.0K | ₩1,716 | -5.7% | ₩34M ($24K) |
| 2025-03-11 | BUY | Market Buy | 정홍걸 Jeong Hong-geol | torture | 11.0K | ₩1,716 | -5.7% | ₩19M ($13K) |
| 2025-03-11 | BUY | 유상신주취득 | 정홍걸 Jeong Hong-geol | torture | 200.0K | ₩1,716 | -5.7% | ₩343M ($238K) |
| 2025-03-11 | BUY | 유상신주취득 | 최경민 Kyeongmin Choi | general manager | 15.0K | ₩1,716 | -5.7% | ₩26M ($18K) |
| 2024-03-08 | BUY | Market Buy | 최경민 Kyeongmin Choi | general manager | 597 | ₩2,945 | -45.1% | ₩2M ($1K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Adbiotech. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.